Starling Oncology, Inc.
STLN- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001799191
In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 119 institutions reported holding it in 13F filings for Q2 2026, worth $217.6M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Starling Oncology, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 45 | 47 | +2 |
| Shares | 18.4M | 17.3M | −1.19M (−6.4%) |
| Value | $37.6M | $27.2M | −$10.4M (−27.6%) |
New holders (7)
Institutions that held Starling Oncology, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FourWorld Capital Management LLC | 250,359 | $395.6K | 0.39% |
| Quattro Financial Advisors LLC | 55,960 | $88.4K | 0.03% |
| Lee Financial Co | 27,980 | $44.2K | 0.01% |
| HighTower Advisors, LLC | 27,980 | $44.0K | 0.00% |
| Nwam LLC | 27,679 | $24.5K | 0.00% |
| UBS Group AG | 10,326 | $16.3K | 0.00% |
| Kirr Marbach & Co LLC | 2,725 | – | – |
Sold out (5)
Institutions that held Starling Oncology, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Josh Arnold Investment Consultant, LLC | 1,856,329 | $3.79M |
| Marshall Wace, LLP | 39,282 | $80.1K |
| Jane Street Group, LLC | 28,187 | $57.5K |
| Prelude Capital Management, LLC | 19,629 | $40.0K |
| Cubist Systematic Strategies, LLC | 12,320 | $25.1K |